Katharina Werkstetter

Katharina Werkstetter

Auto-generated profile, based on publicly available information

Katharina Werkstetter

Abteilung für Pädiatrische Gastroenterologie & Hepatologie, Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital, Klinikum der Ludwig-Maximilians-Universität München, München, Deutschland

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2012 in Journal of Crohn's and Colitis
Verified
Journal Article
Closed access
KWKatharina J. Werkstetter
Katharina J. Werkstetter
JUJennifer Ullrich
Jennifer Ullrich
SSStephanie B. Schatz
Stephanie B. Schatz
CPChristine Prell
Christine Prell
BKBerthold Koletzko
Berthold Koletzko
SKSibylle Koletzko
Sibylle Koletzko
Physical activity is important for muscle and bone strength in the growing child and may be impaired in paediatric patients with inflammatory bowel disease (IBD) even during quiescent disease. The SenseWearPro(2) armband allows to measure physical activity under everyday life conditions. Thirty-nine IBD patients (27 Crohn's disease, 12 ulcerative colitis, 24 boys) in remission (n=26) or with only mild disease activity (n=13) were compared to 39 healthy age and sex-matched controls. Body weight, height, body mass index (BMI), lean body mass as phase angle α (determined by bioelectrical impedance analysis), and dynamometric grip force were expressed as age- and sex-related Z-scores. SenseWearPro(2) armbands were applied for three consecutive days to record number of steps, duration of physical activity and sleeping time. Quality of life was assessed with the German KINDL and IMPACT III questionnaires, energy intake with prospective food protocols. Differences between patients and pair-matched controls were analysed by paired t-test. Patients showed lower Z-scores for phase angle α (difference -0.72; 95% CI [-1.10; -0.34]) and lower grip strength (-1.02 [-1.58; -0.47]) than controls. They tended towards lesser number of steps per day (-1339 [-2760; 83]) and shorter duration of physical activity (-0.44 h [-0.94; 0.06]), particularly in females and patients with mild disease. Quality of life and energy intake did not differ between patients and controls. In spite of quiescent disease lean body mass and physical activity were reduced. Interventions to encourage physical activity may be beneficial in this lifelong disease.

30 August 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
MGMaria Grunewald
Maria Grunewald
CHChristian Hellmuth
Christian Hellmuth
FKFranca F. Kirchberg
Franca F. Kirchberg
MMMaria Luisa Mearin
Maria Luisa Mearin
RARenata Auricchio
Renata Auricchio
HDHans Demmelmair
Hans Demmelmair
Human milk composition is variable. The identification of influencing factors and interdependencies of components may help to understand the physiology of lactation. In this study, we analyzed linear trends in human milk composition over time, the variation across different European countries and the influence of maternal celiac disease. Within a multicenter European study exploring potential prevention of celiac disease in a high-risk population (PreventCD), 569 human milk samples were donated by women from five European countries between 16 and 163 days postpartum. Some 202 mothers provided two samples at different time points. Protein, carbohydrates, fat and fatty acids, insulin, adiponectin, and insulin-like growth factor II (IGF-II) were analyzed. Milk protein and n-6 long chain polyunsaturated fatty acids decreased during the first three months of lactation. Fatty acid composition was significantly influenced by the country of residence. IGF-II and adiponectin concentrations correlated with protein content (r = 0.24 and r = 0.35), and IGF-II also correlated with fat content (r = 0.36), suggesting a possible regulatory role of IGF in milk macronutrient synthesis. Regarding the impact of celiac disease, only the level in palmitic acid was influenced by this disease, suggesting that breastfeeding by celiac disease mothers should not be discouraged.

1 December 2020 in Clinical Nutrition
Verified
Journal Article
Closed access
ABAnnecarin Brückner
Annecarin Brückner
KWKatharina Julia Werkstetter
Katharina Julia Werkstetter
KFKlara Frivolt
Klara Frivolt
ESEngy Shokry
Engy Shokry
MAMohamed Ahmed
Mohamed Ahmed
TSTobias Schwerd
Tobias Schwerd

1 August 2016 in Journal of Autoimmunity
Verified
Journal Article
Closed access
FKFranca F. Kirchberg
Franca F. Kirchberg
KWKatharina J. Werkstetter
Katharina J. Werkstetter
OUOlaf Uhl
Olaf Uhl
RARenata Auricchio
Renata Auricchio
GCGemma Castillejo
Gemma Castillejo
CHChristian Hellmuth
Christian Hellmuth

Verified
Journal Article
Open access
PDF file
ÁDÁdám Diós
Ádám Diós
BSBharani Srinivasan
Bharani Srinivasan
JGJudit Gyimesi
Judit Gyimesi
KWKatharina Werkstetter
Katharina Werkstetter
RVRudolf Valenta
Rudolf Valenta
IKIlma Rita Korponay-Szabó
Ilma Rita Korponay-Szabó
Celiac disease (CeD) is a conditional autoimmune disorder with T cell-mediated immune response to gluten coupled with antibody production to gliadin and the self-protein tissue transglutaminase (TG2). TG2 contributes to the CeD pathomechanism by deamidating gliadin, thereby generating more immunogenic peptides. Anti-gliadin antibodies may appear before the autoantibody production. The scope of this study was to dissect these early antibody responses by investigating serum samples collected during the PreventCD prospective double-blind study, where infants with high CeD risk were randomized to 200 mg daily gluten intake or placebo from 4 to 6 months of age, followed by frequent blood testing on regular gluten consumption in both groups. After primary gluten intake, children with or without later CeD produced IgA and IgG antibodies which preferentially recognized non-deamidated gliadin peptides. At CeD development with anti-TG2 seroconversion, there was a significant increase in the antibody reaction toward deamidated gliadin peptides (DGP), with maturation in the binding strength for the PEQPFP gamma-gliadin core peptide. The earliest produced autoantibodies targeted TG2’s celiac epitope 2. Our results reveal a qualitative change in the gliadin-directed humoral immune response at the time when anti-TG2 antibodies appear, but anti-DGP antibodies in the absence of anti-TG2 antibodies are not disease-predictive.

22 June 2020 in Der Gastroenterologe
Verified
Journal Article
Closed access
PDF file
KWK. Werkstetter
K. Werkstetter
SKSibylle Koletzko
Sibylle Koletzko